Lower MTHFR activity, in turn, is thought to reduce the production of nitric oxide (NO), which can affect control of blood pressure
Importantly, the majority of these experimental findings have been further corroborated in human NS workers, with clear differences compared to day workers observed across multiple biological mechanisms (including oxidative stress, immune dysfunction, inflammation, melatonin disruption, clock gene alterations, epigenetic changes, telomere attrition, and hormonal imbalances)
It combines three peptides with specific roles: KPV as a potent anti inflammatory and gut modulating peptide, BPC-157 for tissue repair and gastrointestinal healing, and LL-37 as an antimicrobial and immune support peptide
Median survival was just over a month longer with Keytruda treatment at 12.9 months versus 11.5 months
Undermining health limits what any peptide can achieve